A pharmacogenetic study of risperidone on chemokine (C–C motif) ligand 2 (CCL2) in Chinese Han schizophrenia patients
Yuyu Xiong(Henan University of Technology), Shengying Qin(Shanghai Jiao Tong University), Zhiyun Wei(Obstetrics and Gynecology Hospital of Fudan University), Zhenqiang Wu(Shanghai Jiao Tong University), Wenqiang Li(Henan Provincial Institute of Occupational Health), Qinghe Xing(Fudan University), Lu Shen(Nanchang University), Xueli Gong(Shanghai Jiao Tong University), Xi Wu(Sun Yat-sen University), Lin He(Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine), Guoyin Feng(Shanghai Mental Health Center), Yang Li(Shanghai First People's Hospital), Ran Huo(University of Iowa)
Progress in Neuro-Psychopharmacology and Biological Psychiatry
February 3, 2014
Cited by 9
Related Papers
Cytochrome P450 Enzymes and Drug Metabolism in Humans
|International Journal of Molecular Sciences|2021|939
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709
Sclerostin Mediates Bone Response to Mechanical Unloading Through Antagonizing Wnt/β-Catenin Signaling
|Journal of Bone and Mineral Research|2009|623
Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
|Nature Communications|2017|549
Mutations in <i>TUBB8</i> and Human Oocyte Meiotic Arrest
|New England Journal of Medicine|2016|324